EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;33:523-528. doi:10.1016/j.ejcts.2007.12.055
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Cary W. Akins
D. Craig Miller
Marko I. Turina
Nicholas T. Kouchoukos
Eugene H. Blackstone
Gary L. Grunkemeier
Johanna J.M. Takkenberg
Tirone E. David
Eric G. Butchart
David H. Adams
David M. Shahian
Siegfried Hagl
John E. Mayer
Bruce W. Lytle
Right arrow Permission Requests
Google Scholar
Right arrow Articles by Akins, C. W.
Right arrow Articles by Lytle, B. W.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Akins, C. W.
Right arrow Articles by Lytle, B. W.


Editorials

Guidelines for reporting mortality and morbidity after cardiac valve interventions

Cary W. Akinsa,*, D. Craig Millera, Marko I. Turinac, Nicholas T. Kouchoukosb, Eugene H. Blackstonea, Gary L. Grunkemeierb, Johanna J.M. Takkenbergc, Tirone E. Davida, Eric G. Butchartc, David H. Adamsb, David M. Shahianb, Siegfried Haglc, John E. Mayerb, Bruce W. Lytlea

a The American Association for Thoracic Surgery, Beverly, MA, United States
b The Society of Thoracic Surgeons, Chicago, Il, United States
c The European Association for Cardio-Thoracic Surgery, Windsor, Berks, United Kingdom

Received 11 December 2007; accepted 11 December 2007.

* Corresponding author. Address: Cox 648, Massachusetts General Hospital, 55 Fruit Street, Boston, MA 02114, United States. Tel.: +1 617 726 8218; fax: +1 617 726 3781. (Email: cakins@partners.org).

Abbreviations: CI = confidence interval

The first 300 words of the full text of this article appear below.

Since the initial publication of ‘Guidelines for Reporting Morbidity and Mortality After Cardiac Valvular Operations’ in 1988, [1] followed by a revised version in 1996 [2], valvular heart surgery has evolved to include an enhanced understanding of patient- and disease-related factors affecting outcomes, increased numbers of valve repairs, more operations performed for patients with minimal symptoms, new prostheses, novel repair methods, and the emergence of percutaneous interventional (catheter-based) valve repair and replacement. To adapt to this changing environment, the Councils of the American Association for Thoracic Surgery, The Society of Thoracic Surgeons, and The European Association for Cardio-Thoracic Surgery have directed an Ad Hoc Liaison Committee for Standardizing Definitions of Prosthetic Heart Valve Morbidity to review current clinical practice to update and clarify these reporting guidelines. The guidelines are intended to cover treatment of all four cardiac valves in both adult and pediatric patients. Further, these guidelines apply uniformly, irrespective of whether the therapy was carried out as a conventional open operation, as a minimally invasive (video-assisted or robotic) surgical procedure, or with percutaneous interventional catheter techniques.

1. Purpose

These reporting guidelines are intended to facilitate analysis and reporting of clinical results of various therapeutic approaches to diseased heart valves such that meaningful comparisons can be made and inferences drawn from investigations of medical, surgical, and percutaneous interventional treatment of patients with valvular heart disease.

2. Early mortality

Early mortality is to be reported as all-cause mortality at 30, 60, or 90 days and depicted by actuarial estimates (with number remaining at risk and confidence intervals [CIs]) or as simple percentages, regardless of the patient's location, be it home or in a health care facility.

3. Definitions of morbidity

3.1 Structural valve deterioration
Structural valve deterioration includes dysfunction or deterioration involving the operated valve (exclusive of infection or thrombosis), as determined by reoperation, autopsy, or clinical investigation. Clinical investigation should include periodic . . . [Full Text of this Article]







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.